| CAR | chimeric antigen receptor |
| EGFR2/HER2 | human epidermal growth factor receptor 2 |
| NK | Natural Killer |
| ICB | immune checkpoint blockade |
| PD-1 | programmed cell death 1 |
| CTLA-4 | cytotoxic T lymphocyte-associated protein 4 |
| Ig | immunoglobulin |
| DNAM-1/CD226 | DNAX Accessory Molecule-1 |
| ITIM | immunoreceptor tyrosine-based inhibition motif |
| TIGIT | T-cell immunoreceptor with Ig and ITIM domains |
| IFN | interferon |
| HCC | hepatocellular carcinoma |
| TNF | tumor necrosis factor |
| TILs | tumor-infiltrating lymphocytes |
| Ab | antibody |
| CML | chronic myeloid leukemia |
| AML | acute myeloid leukemia |
| scFv | single chain variable fragment |
| PBMCs | peripheral blood mononuclear cells |
| KO | knockout |
| gRNA | guide RNA |
| WT | wild-type |
| mAb | monoclonal antibody |
| IC | intracellular signalling domain |
| E:T | effector:target ratio |
| BLI | bioluminescence |